FourThought Financial’s GSK GSK Stock Holding History

FourThought Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$61K	Sell	2,059 -1	-0%	-$38	0.01%	545
2022 Q2	$112K	Buy	2,060 +910	+79%	+$50.2K	0.02%	410
2022 Q1	$63K	Hold	1,150	–	–	0.01%	599
2021 Q4	$63K	Hold	1,150	–	–	0.01%	606
2021 Q3	$54K	Hold	1,150	–	–	0.01%	670
2021 Q2	$57K	Hold	1,150	–	–	0.01%	667
2021 Q1	$51K	Sell	1,150 -6,601	-85%	-$300K	0.01%	683
2020 Q4	$356K	Buy	+7,751	New	+$356K	0.06%	249

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FourThought Financial's GSK Position: Q3 2022 in Review

FourThought Financial reduced its GSK (GSK) stake by 0.05% in Q3 2022, selling an estimated $38 and leaving 2,059 shares worth $61K. The position accounts for 0.01% of the portfolio, ranked #545.

FourThought Financial first reported a position in GSK in Q4 2020 and has held it in 8 quarters since. The position peaked at $356K in Q4 2020. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

FourThought Financial held 2,059 shares of GSK worth $61K as of Q3 2022.
FourThought Financial sold 1 GSK share in Q3 2022, an estimated $38.
GSK made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #545 holding.
FourThought Financial first reported a position in GSK in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's GSK position peaked at $356K in Q4 2020.
743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.